Jasper Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, ladies and gentlemen. Welcome to the 2026 Annual Meeting of the Stockholders of Jasper Therapeutics. I am Jeet Mahal, the company's Chief Executive Officer and President.
At this time, I call the meeting to order. I am pleased to conduct our meeting virtually. The company's Board of Directors has appointed me to act as Chairman of this meeting. Herb Cross, the company's Chief Financial Officer, will act as Secretary of this meeting. I would also like to introduce Kevin McKinney, partner with PricewaterhouseCoopers LLP, our independent registered public accounting firm.
During the question-and-answer period at the end of today's session, Mr. McKinney will be available to answer any appropriate questions you may have, concerning the independent audit.
The Board of Directors has appointed Henry Farrell of Continental Stock Transfer & Trust Company to act as Inspector of Election for this meeting. Mr. Farrell has previously taken his oath as Inspector of an Election. We will file
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
